Cite
Yuan X, Wang LU, Xue J, et al. Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer. Oncol Lett. 2015;10(3):1902-1906doi: 10.3892/ol.2015.3395.
Yuan, X., Wang, L. U., Xue, J., Li, L. I., & Zhang, J. (2015). Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer. Oncology letters, 10(3), 1902-1906. https://doi.org/10.3892/ol.2015.3395
Yuan, Xiuhong, et al. "Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer." Oncology letters vol. 10,3 (2015): 1902-1906. doi: https://doi.org/10.3892/ol.2015.3395
Yuan X, Wang LU, Xue J, Li LI, Zhang J. Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer. Oncol Lett. 2015 Sep;10(3):1902-1906. doi: 10.3892/ol.2015.3395. Epub 2015 Jun 19. PMID: 26622772; PMCID: PMC4533712.
Copy
Download .nbib